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Purpose: To evaluate role of quantitative assessment of chemical shift MR imaging and chemical shift
subtraction technique in differentiating adenomatous from non-adenomatous adrenal lesions with com-
parison of accuracy level of each technique.
Materials and methods: A prospective study was carried out from 4-2014 to 5-2016 using 1.5T MRI. In-
phase/opposed phase MRI sequences were applied for 52 patients having 58 adrenal lesions, 18 were
hyper functioning and 40 were non-functioning. Lesions signal changes between in- and opposed phase
sequences and post processing was done to calculate different quantitative chemical shift parameters
using spleen, paraspinal muscle, and liver as a reference tissues. Additionally subtraction chemical shift
MR technique on selected 16 cases was applied.
Results: Signal intensity index and the two formulas of adrenal to spleen ratio were more accurate than
other quantitative chemical shift MRI parameters in discrimination between adenomatous and nonade-
nomatous adrenal lesions with selected cutoff value 23.4% for the signal intensity index, 0.72 and
27.82% for adrenal to spleen ratio% using the old and new formulas respectively. Chemical shift subtrac-
tion technique expressed significant difference between adenomas and non-adenomatous adrenal lesions
where adenomas had ratio of 108.87 or more, and the non-adenomatous lesions had ratio of 47.74 or less
with selected cutoff value 173.0475.
Conclusion: The signal intensity index and adrenal to spleen ratio are the most reliable quantitative
chemical shift MRI methods in differentiation of adrenal adenomas from other non-adenomatous adrenal
solid lesions. Chemical shift subtraction MRI is a recent technique that gives highly confident discrimina-
tion between two categories of pathology without using of any reference organ.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
In spite of its small size, the adrenal gland included a wide
range of diseases, up to 9% of them detected in autopsy. Disease
spectrum includes hormonal dysfunction abnormalities, benign
and malignant neoplastic lesions (whether primary or secondary)
as well as infiltrative disease [1].Recent revolutions in the field of laboratory investigations and
radiological imaging much facilitated the diagnosis of such disease
varieties [2,3].
Most of incidentalomas (incidentally discovered adrenal
lesions), are non-functioning and being benign while 10% are func-
tional and less than 5% being malignant. The difficulty that most of
incidentalomas, whatever their nature, seem to be of rather similar
pattern in cross sectional imaging [4–6].
Incidence of adrenal adenomas increased in correlation with
patient’s age reaching 6% of over sixty patients. Up to 50% of
detected adrenal masses in patient with a known primary extra-
adrenal malignancy considered metastatic. The dilemma being in
differentiating benign adenoma from metastasis as the later willique in
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hence appropriate characterization is mandatory [7].
MRI applications in adrenal imaging is of great value due to high
capability for tissue characterization, limiting the differential diag-
nosis or reaching an accurate final diagnosis [8].
The chemical shift is being the most sensitive technique used
for detection of lipid in adrenal lesion even with very minute quan-
tities and depending on this fact, chemical shift MRI technique is
sensitive for diagnosing adrenal adenoma; even it could replace
unenhanced CT with avoidance of hazards of radiation exposure.
High sensitivity and specificity based on differentiating adrenal
adenoma with abundant intra-cytoplasmic fat content from adre-
nal metastasis which don’t show any signal changes between in
phase to out phase imaging [9].
Adrenal masses are more accurately characterized by quantita-
tive rather than qualitative method of chemical shift MR [10,11].
Multiple quantitative chemical shift imaging studies have been
reported trying to reach accurate diagnosis of adrenal masses using
different methodology with variable magnetic field strengths, gra-
dient strengths, and different Ref. tissues in the formulas used for
quantitative calculation of signal changes including the spleen
[12–14], the liver [15–18] and paraspinal muscles [17,19].
In current study, we aimed to evaluate role of quantitative
assessment of chemical shift MR imaging and chemical shift sub-
traction technique in differentiating adenomatous from non-
adenomatous adrenal lesions with comparison of accuracy level
of each technique.2. Materials and methods
Current prospective study was carried out between 4 and 2014
and 5–2016, included 52 patients presented with 58 solid adrenal
lesions that were evaluated using MRI 1.5 T. Included patients hav-
ing previously diagnosed adrenal lesion based mainly upon previ-
ous CT studies. Patient’s age range was from 21 to 77 years (mean
44.77 years), equal male to female ratio and right to left side ratio
was 3:2.8. The study was approved by the faculty ethics committee
and informed consent was taken from each patient.
Exclusion criteria included lesions having predominate extra-
cellular fat contents as myelolipoma, cases of adrenal hyperplasia
and hemorrhage (in newborns or due to trauma), purely cystic
lesions (simple cyst or pseudo-cyst) and adrenal lymphatic malfor-
mation. Also solid lesions with longest diameter less than 1 cm
were excluded because of the technical difficulty of setting the
region of interest over them without avoidance of partial volume
artifacts production at the lesion edges.
Histopathological date (whether open or laparoscopic
adrenalectomy) used to confirm the diagnosis of all adrenal
lesions. Metastatic tumors were assessed by percutaneous needle
biopsy in 4 cases presented with 6 adrenal masses.
MRI examinations was done using 1.5-T superconductive unit
(1.5 T Philips Achieva Gyroscan, Best, Netherlands) for 52 cases,
using phased-array body coil. Lesion localization done first using
routine sequences followed with chemical shift sequence at the
adrenal lesion level using in-phase/opposed-phase sequence.
Chemical shift sequence is a refocused dual gradient echo
sequence using the following parameters (fast field echo (FFE),
TR 130 ms, double TEs of 4.6 and 2.3 ms) used for out-of-phase
and in-phase images respectively, (flip angle 80, slice thickness
3 mm, intersection gap 0.3 mm, FOV390/1.4 and 192  256 matrix
size, number of echoes = 2).
Spleen, liver, and para-spinal muscles were imaged at same
slice as the adrenal lesion whenever possible. Patients held their
breath after full expiration with each breath-hold lasted about
16–20 s and the total imaging time was less than 2 min.Please cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. EgypLast group of cases (17 cases) presented throughout the past
year of the study (distributed as 11 adenomas, 4 pheochromocy-
tomas, 1 metastasis and 1 carcinoma)subjected to additional
chemical shift MRI sequence which performed using a double-
echo fast low-angle shot (FLASH) sequence obtained at the level
of the adrenal lesion using the following parameters(single 19 s
breath hold, TR 133 ms, doublets of2.2 and 4.4 ms for opposed-
phase and in-phase respectively, flip angle 75, 6-mm slice thick-
ness, 192  256 matrix, field of view of 300–350 mm, intersection
gap 0.6 mm, and one signal acquisition). Subtraction images
obtained by subtracting opposed phase images from in-phase
images using the system’s commercially available software.
Post processing with Philips-EWS workstation where signal
intensities of adrenal lesions and their reference tissues (spleen,
liver and ipsilateral para-spinal muscles) measured using gener-
ated circular regions of interest (ROI) covering widest dimension
of the adrenal lesion, avoid partial volume artifact at the lesion
edge, avoiding necrotic, cystic, hemorrhagic and calcific portions
whenever possible.
Regarding the reference tissues, ROI must be as large as possible
to be representative of the particular tissue excluding intrahepatic
blood vessels (best at posterior segment of right lobe) and also
avoid putting the ROI on obvious fat striations in the paraspinal
muscle and other reference organs whenever possible. If splenic
tissue was not present on the same slice, the closest available slice
was used.
Measurements were repeated at same axial images and same
adrenal position and selected reference tissues in both in-phase
and out of phase corresponding images with similar surface area
of ROI in similar location in both sequences. In post processing,
subtraction of out of phase from in-phase chemical shift images
was done then the subtracted images were quantitatively
calculated.
Four quantitative chemical shift parameters of signal intensity
(SI) changes between the out of-phase and the in-phase images
were calculated as follows:
 Signal intensity index (SII): calculated used this formula [(SI on
in-phase imaging-SI on opposed-phase imaging)/(SI on in-phase
imaging)]  100%.
 Adrenal to spleen ratio: calculated using new formula as
{[(adrenal SI on opposed-phase imaging/spleen SI on opposed-
phase imaging)/(adrenal SI on in-phase imaging/spleen SI on
in-phase imaging)]–1}  100%.
 Adrenal to liver ratio: calculated as {[(adrenal SI on opposed-
phase imaging/liver SI on opposed-phase imaging)/(adrenal SI
on in-phase imaging/liver SI on in-phase imaging)] – 1}  100%.
 Adrenal to muscle ratio: calculated as {[(adrenal SI on opposed-
phase imaging/muscle SI on opposed-phase imaging)/(adrenal
SI on in-phase imaging/muscle SI on in-phase imaging)] –
1}  100%.
Previously, adrenal to spleen ratio was calculated as {[(adrenal
SI on opposed-phase imaging/spleen SI on opposed-phase imag-
ing)/(adrenal SI on in-phase imaging/spleen SI on in-phase imag-
ing)] and that was included in current study to distinguish the
most sensitive and specific ratio for diagnosis of adrenal adenoma.3. Radiologist’s observations and statistical analysis
Images of different adrenal lesions were presented for two
experienced radiologists of abdominal MRI interpretation (A.R.
and A.H.) who had 6 and 12 years experience in the field of geni-
tourinary imaging respectively. Both of themwere asked to classify
lesions whether adenomatous or non-adenomatous depending onift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
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tioned four chemical shift quantitative parameters (including
adrenal-to-spleen ratio using the old formula as mentioned
before). Comparing the five parameters using independent samples
t-test, scatter plotting and ROC curves using IBM SPSS version 20
software computed program.4. Results
The quantitative chemical shift parameters, namely signal
intensity index, adrenal to spleen, adrenal to liver, and adrenal to
muscle ratios were used to differentiate both types of adrenal
lesions to verify statistically significant difference. The mean val-
ues of both types were tested using Mann-Whitney test and anal-
ysis of the results was presented in Table 1.
Current results showed mean ± SD diameters of adenomatous
adrenal lesions were 2.4 ± 0.8 (ranged from 1.4 to 4.3 cm) and that
for non-adenomatous lesions were7.3 ± 3.5 (ranged from 2.8 to
14.5 cm).
Also mean and standard deviation of signal intensities for adre-
nal adenomas was 54.52 ± 14.16 (range, 30.50–71.20), and
6.65 ± 5.56 (range, 0.40–16.30) for non-adenomatous adrenal
lesions. Using old formula of adrenal to spleen ration%, the mean
and standard deviation of signal intensities for adrenal adenomas
was 0.48 ± 0.15 (range, 0.30–0.69), while was 0.95 ± 0.08 (range,
0.75–1.06) for non-adenomatous adrenal lesions. On the other
hand, using the new formula of adrenal to spleen ration%, the meanTable 1
Comparison of chemical shift quantitative parameters in differentiation of adenomatous
parameter and its significance.
Chemical shift parameter Diagn
Non
Adrenal signal intensity% Minimum 0.40
Maximum 16.30
Mean 6.65
SD 5.56
Median 5.00
Adrenal to spleen ratio% (old formula) Minimum 0.75
Maximum 1.06
Mean 0.95
SD 0.08
Median 0.98
Adrenal to spleen ratio (new formula) Minimum 24.9
Maximum 6.00
Mean 4.52
SD 8.33
Median 2.00
Adrenal to liver ratio% Minimum 8.40
Maximum 46.37
Mean 7.24
SD 14.62
Median 0.55
Adrenal to muscle ratio% Minimum 9.31
Maximum 35.61
Mean 6.46
SD 12.46
Median 2.50
Chemical shift subtraction MR images Minimum 4.17
Maximum 232.0
Mean 157.8
SD 102.4
Median 232.0
P: Mann-Whitney test.
* P < 0.01 (significant).
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discriminating adenomatous from non adenomatous adrenal solid lesions. Egyp52.38 ± 14.54 (range, 70.30 to 30.68), while was 4.52 ± 8.33
(range, 24.95 to 6.00) for non-adenomatous lesions.
Using the scatterplots to compare between the chemical shift
parameter values to discriminate adenomatous from non-
adenomatous adrenal lesions, we found that there was no overlap
signal intensity difference resulted from the chemical shift equa-
tions between both adrenal adenomas and non-adenomatous
lesions using the first three mentioned chemical shift parameters
and this was demonstrated in Fig. 1(a–c) that showed scatterplot
of the quantitative data of both adrenal adenomatous and non-
adenomatous using the adrenal signal intensity % (Fig. 1a), old for-
mula of adrenal to spleen ratio% (Fig. 1b), and new formula of adre-
nal to spleen ratio% (Fig. 1c), chemical shift parameters
respectively.
Results of adrenal to liver ratio % showed that the mean and
standard deviation of signal intensity difference resulted from
the chemical shift equation for adenomas was with
45.51 ± 19.03 (range, 69.43 to 4.65), while it was
7.24 ± 14.62 (range, 8.40 to 46.37) for non-adenomatous adrenal
lesions. Mean and standard deviation of signal intensity difference
resulted from the chemical shift equation for adrenal to muscle
ratio % for adenomas was with 41.41 ± 22.17 (range, 69.85 to
4.50), while was 6.46 ± 12.46 (range, 9.31 to 35.61) for non-
adenomatous adrenal lesions.
Small overlap in signal intensity difference resulted from the
chemical shift equations was found when using the adrenal to liver
ratio % and adrenal to muscle ratio %, seen in Fig. 1(d–f) which
showed scatterplot of the quantitative data of both adrenal adeno-and non adenomatous adrenal lesions with the mean, St. deviation, range of each
osis Total P
adenoma Adenoma
30.50 0.40 <0.001*
71.20 71.20
54.52 27.39
14.16 25.97
57.15 15.05
0.30 0.30 <0.001*
0.69 1.06
0.48 0.75
0.15 0.26
0.44 0.82
5 70.30 70.30 <0.001*
30.68 6.00
52.38 25.26
14.54 26.46
55.98 17.71
69.43 69.43 <0.001*
4.65 46.37
45.51 15.62
19.03 31.11
41.13 5.08
69.85 69.85 <0.001*
4.50 35.61
41.41 14.28
22.17 29.45
47.38 5.21
108.87 4.17 <0.001*
0 488.98 488.98
6 287.67 214.11
5 120.48 127.39
0 271.60 232.00
ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
Fig. 1. Scatterplots show differences in all calculated quantitative chemical shift parameters used to differentiate adenomas from non-adenomatous adrenal lesions. No
significant overlap seen in the three parameters adrenal signal intensity, adrenal to spleen ratio using the new and old formula respectively (a–c), considerable overlap is seen
in adrenal to liver ratio (d), and adrenal to muscle ratio (e) and subtraction chemical shift technique (f).
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(Fig. 1d) and adrenal to muscle ratio % (Fig. 1e).
The result of subtraction chemical shift measurements showed
that the mean and standard deviation signal intensities of chemical
shift subtraction MR images for adenomatous adrenal lesions wasPlease cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egypwith 287.67 ± 120.48 (range, 108.87–488.98) while was
157.86 ± 102.45 (range, 4.17–232) for non-adenomatous adrenal
lesions.
There was significant overlap in signal intensity between adre-
nal adenomas and non-adenomatous lesions seen in Fig. 1(f) whichift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
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adenomatous and non-adenomatous chemical shift subtraction
MR images.
All measured quantitative chemical shift parameters and
chemical shift subtraction technique showed significant statisticalFig. 2. Graph shows receiver operating characteristic curves (ROC) using the all calculat
new formula (II), adrenal to spleen ratio old formula (III), adrenal to liver ratio (IV), adr
adenomatous and non-adenomatous adrenal solid lesions.
Please cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egypdifference between adenomas and non-adenomas lesions with
(p < 0.001).
The ROC curves of the all the calculated quantitative chemical
shift parameters used for differentiation were represented in
Fig. 2. Az values of the mean area under curve (AUC) and standarded chemical shift parameters; signal intensity index (I) and adrenal to spleen ratio
enal to liver ratio (V) and subtraction chemical shift technique (VI) to differentiate
ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
Table 2
Mean area under the curve (Az) values with standard error and the statistic significance of all quantitative chemical shift parameters for differentiation of adrenal adenomas from
other non adenomatous adrenal lesions with coordinates of each curve.
Chemical shift parameter Area
(Az)
Std.
errora
Asymptotic
sigb
Asymptotic 95%
confidence interval
Coordinates of the curve
Lower
bound
Upper
bound
Cut off value Sensitivity 1-Specificity
Signal intensity index % 1.000 0.000 0.000 1.000 1.000 Positive if greater than or equal to
23.40%
1.00 0.00
Adrenal to spleen ratio% (old
formula)
1.000 0.000 0.000 1.000 1.000 Positive if lesser than or equal to
0.72
1.00 0.00
Adrenal to spleen ratio% (new
formula)
1.000 .000 .000 1.000 1.000 Positive if lesser than or equal to
27.82
1.00 0.00
Adrenal to liver ratio % 0.986 0.011 0.000 0.965 1.000 Positive if lesser than or equal to
20.0050
0.923 0.00
Adrenal to muscle ratio % 0.977 0.015 0.000 0.948 1.000 Positive if lesser than or equal to
6.0500
0.923 0.118
Subtraction chemical shift 0.838 0.057 0.000 0.727 0.949 Positive if lesser than or equal to
173.0475
0.808 0.647
a Under the nonparametric assumption.
b Null hypothesis: true area = 0.5.
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are represented in Table 2.
Az value for signal intensity index and adrenal to spleen ratio
with its old and recent formulae were the highest values among
all applied parameters with the Az value = 1.000 for each of them
and the statistical significance (p = 0.000) was equal for all chemi-
cal shift parameters as well as for the subtraction chemical shift
technique.
Cases distribution as follow: 24 adenoma cases whether func-
tioning (Fig. 3) or non-functioning (Fig. 7), 16 pheochromocytoma
(Fig. 9), 8 adreno-cortical carcinoma (Fig. 5 with IVC thrombosis
and Fig. 6), 6 metastatic (Fig. 8), 2 ganglio-neuroma (Fig. 4) and
finally two sarcomas.
All the adenomas had signal intensity indexes of 30.5% or more,
whereas all the non-adenomatous adrenal lesions had signal inten-
sity indexes of 16.3% or less. If the value for the signal intensity
index was taken from this range (16.3–30.50%), the accuracy for
differentiating adenomas from non-adenomatous adrenal solid
lesions was 100%, and cutoff value calculated from the ROC curve
indicate that any adrenal lesion with signal intensity index equal
to or more than 23.4% indicate adenoma.
Using old formula of adrenal to spleen ratio, all adrenal adeno-
mas had ratio of 0.69 or less, whereas all the non-adenomatous
lesions ratio of 0.72 or more. If this range was taken (0.69–0.72),
the accuracy for differentiating adenomas from non-
adenomatous adrenal solid lesions was 100%, and the cutoff value
calculated from ROC curve indicate that any adrenal lesion with
adrenal to spleen ratio (old formula) less than or equal to 0.72 indi-
cate adenoma.
On the other hand, using new formula of adrenal to spleen ratio
%, all adrenal adenomas had ratio of 30.68% or less, whereas all
the non-adenomatous lesions ratio of 24.29% or more. If the value
for the adrenal to spleen ratio% with new formula was taken from
this range (30.68 to 24.29%), the accuracy for differentiating
adenomas from non-adenomatous adrenal solid lesions was
100%, and the cutoff value calculated from the ROC curve indicate
that any adrenal lesion with adrenal to spleen ratio% (new formula)
lesser than or equal to 27.82% indicate adenoma.
Using adrenal to liver ratio% we found all adrenal adenomas had
ratio of 4.65% or less, all the non-adenomatous lesions ratio of
8.7% or more. If the value for the adrenal to liver ratio% was taken
from this range (8.7 to 4.65%), the accuracy for differentiating
adenomas from non-adenomatous adrenal solid lesions wasPlease cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egyp92.3%, and the cutoff value calculated from the ROC curve indicate
that any adrenal lesion with adrenal to liver ratio% lesser than or
equal to 20.005% indicate adenoma.
Finally, using adrenal to muscle ratio%, all adrenal adenomas
had ratio of 4.50% or less, whereas all the non-adenomatous
lesions ratio of 9.31% or more. If the value for the adrenal to mus-
cle ratio% was taken from this range (9.31 to 4.50%), the accu-
racy for differentiating adenomas from non-adenomatous adrenal
solid lesions was 92.3%, and the cutoff value calculated from the
ROC curve indicate that any adrenal lesion with adrenal to muscle
ratio% lesser than or equal to 6.05% indicative for adenoma.
However, using ROC curve for chemical shift subtraction signal
intensities it expressed significant difference between adenomas
and non-adenomatous adrenal lesions with excellent area under
the ROC curve (Az = 0.838) and favorable sensitivity and specificity
characteristics, with the (p < 0.000) and suggested cutoff value of
the signal intensity selected was 173.0475, as we found all adrenal
adenomas had ratio of 108.87 or more, whereas all the non-
adenomatous lesions ratio of 47.74 or less. If the value for the
chemical shift subtraction was taken from this range (47.74–
108.87), the accuracy for differentiating adenomas from non-
adenomatous adrenal solid lesions was 80.8%.5. Discussion
Characterizing nature of indeterminate adrenal mass with MRI
updates was crucial along last years as imaging features for many
lesions were not characterizing. As most adrenal adenomas contain
intra-cytoplasmic lipid, whereas most of other solid lesions (nota-
bly malignant ones) contain no fat, so idea of differentiating benign
adenomas from other solid adrenal tumors using chemical shift
MRI imaging could limit the considerable imaging overlap guiding
for the proper decision of management. Special situation of confu-
sion faced if patient with known primary malignant lesion where
differentiating adrenal adenomas from metastasis is a must [20].
Qualitative and quantitative studies using chemical shift meth-
ods to assess presence of fat in adrenal lesions through in-and
opposed phase MRI sequences based on visual comparison of the
signal drop between in- and opposed-phase images whereas quan-
titative method compared with adjacent structures in same section
as a visual reference (as example with spleen, liver and muscles)
[21].ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
Fig. 3. 31-years female with both laboratory and post excision biopsy proved left adrenal aldosterone-producing adrenocortical adenoma. A, Axial in-phase MR image shows
left adrenal mass (arrow) slightly isointense signals to spleen and paraspinal muscle. B, Axial opposed-phase MR image shows lower signal intensity of mass (arrow)
compared to spleen and compared to its signal on A. Signal intensity index was 30.5%, adrenal to spleen ratio was 0.69, adrenal to spleen ratio% was 30.68%, adrenal to liver
ratio% was 31.61% and adrenal to muscle ratio% was 31.5%.
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assumed that adrenal-to-spleen ratio is the best quantitative
chemical shift parameter in such discrimination and found no
overlap in the results between adenomas and non-adenomas when
the spleen was used as a reference organ rather than liver and
paraspinal muscles (which showed some overlap in their results
that was attributed to fatty infiltration of liver and adipose tissue
in para-spinal muscles that altered the result during calculating
the ratio of signal drop in opposed phase).
In the current study, the signal intensity index and adrenal-to-
spleen ratio using either old or new formula considered the pre-
ferred parameters used in discrimination based on their better Az
values seen on ROC analysis (1.000) however all other applied
quantitative chemical shift parameters showed significant differ-
ence between adenomatous and non-adenomatous lesions
(p < 0.001).Please cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. EgypMcNicholas et al. [22] stated an algorithmic approach to adre-
nal masses based on their density in non-contrast CT and corre-
late it with MRI chemical shift adrenal to spleen ratio (ASR) and
suggested that ASR less than 0.7 is indicative of benign adrenal
lesion with no need for further work up were ASR more than
0.7 is probably malignant and biopsy is recommended for definite
diagnosis.
In the current results, we much agreed with their results as
when using old formula of adrenal to spleen ratio, all adrenal ade-
nomas had ratio of 0.69 or less, while all non-adenomatous lesions
had ratio of 0.72 or more with suggested cutoff value less than or
equal to 0.72 indicative for adenoma. On the other hand when
applying the new formula, we found all adrenal adenomas had
ratio of 30.68% or less, whereas all the non-adenomatous lesions
had ratio of 24.29% or more with the suggested cutoff value less
than or equal to 27.82% indicated adenoma.ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
Fig. 4. 21-years male with biopsy proven right adrenal ganglioneuroma A, Axial in-phase MR image shows right adrenal mass (arrow) that slightly isointense in signal to
spleen and paraspinal muscle. B, Axial opposed-phase MR image shows no significant drop of signal noted in the right adrenal mass (arrow) compared to its signal on A. Signal
intensity index was 1.6%, adrenal to spleen ratio was 0.98, adrenal to spleen ratio% was 2%, adrenal to liver ratio% was 16.63% and adrenal to muscle ratio% was 4.21%.
8 A.H. Afifi et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxPoor differentiation between adenomas and non-adenomatous
lesions on using previous chemical shift imaging depending only
on their signal intensity likely attributed to dispersion of lipid con-
tent in adenomas and small amount of lipid content found in non-
adenomatous tumors as reported by Mitchell et al. [23] and Reinig
et al. [24] showing that using signal intensity index is less reliable
than other ratios.
Tsushima et al. [25] stated that signal intensity index for ade-
noma were significantly higher than other non-adenomas (metas-
tasis and pheochromocytoma) with no overlap and reported that
adenomas had SI indexes of more than 5%, while all metastatic
tumors and pheochromocytomas had SI indexes of less than 5%.
Fujiyoshi et al. [20] and Barzilay and Pazianos [26] stated that
the signal intensity index showed the greatest Az value of all quan-
titative chemical shift parameters eliminating the problem of sig-
nal intensity variability produced by using reference tissues with
other parameters with an 100% accuracy when the cutoff value
was 11.2–16.5%.
Sandrasegaran et al. [16] proved that figure of 23% is better than
16.5% as a cutoff value of signal intensity index. Al-Hawary et al.Please cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egyp[15] stated that the signal intensity index measurement of any
lesion is depending basically on the parameters used in chemical
shift imaging as increasing T1 weighting by increasing the
flip angle could result in overestimation of the fat content of the
lesion.
In the current study, signal intensity index showed an equal
accuracy for adrenal-to-spleen ratio with both Az areas being
(1.000) and accuracy for differentiating adenomas from non-
adenomatous solid lesions was 100%, and the cutoff value of signal
intensity index greater than or equal to 23.4% indicate adenoma.
Although the signal intensity indexes for all adrenal adenomas
were dispersed in our study, still they were all in the positive range
with the lowest SI index 23.4% this is compatible to which stated
by Tsushima et al. [25] as some adenomas had signal intensity
indexes less than 10% and also matched with that stated by
Fujiyoshi et al. [20] who mentioned lowest signal intensity index
for adrenal adenoma was 16.5%.
Tsushima et al., also stated that the mean signal intensity
indexes for adenomas and metastatic tumors were 17.0 ± 8.2%
and 6.8 ± 9.2%, respectively and Fujiyoshi et al., stated that theift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
Fig. 5. 54-years male with biopsy proven left adrenal carcinoma. A Axial in-phase MR image shows left adrenal mass (yellow arrow) that expresses isointense signal to spleen
and paraspinal muscle with tumor thrombus seen extending into the left renal vein (white thin arrow) crossing the midline and not reaching the IVC. B, Axial opposed-phase
MR image shows no significant drop of signal noted in the left adrenal mass (yellow arrow) nor in tumor thrombus (white thin arrow) compared to its signal on A. Signal
intensity index was 6.3%, adrenal to spleen ratio was 0.98, adrenal to spleen ratio% was 1.92%, adrenal to liver ratio% was 8.4% and adrenal to muscle ratio% was 22.2%.
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were 57.49 ± 15.33% and 0.22 ± 6.88%, respectively. In the current
study, we found the mean signal intensity indexes for adrenal ade-
nomas and non-adenomatous lesions included metastasis were
54.52 ± 14.16% and 6.65 ± 5.56 respectively with mean signal
intensity index of 0.74 ± 0.35.
Image subtraction as a post processing technique in evaluating
efficacy of chemical shift MRI and characterizing adrenal masses
have been reported by Savci et al. [27] and Korivi and Elsayes
[28] when they subtracted opposed-phase images from in-phase
images in an attempt to maximize the recognition of lipid content
in adrenal lesions using double-echo chemical shift FLASH imaging
sequence with single breath-hold with the corresponding in-phase
and opposed-phase images obtained from identical anatomic posi-
tion to avoid slice mis-registration followed by measuring signal
intensity of adrenal masses in subtracted images.
Savci et al., stated that there was a statistically significant dif-
ference in signal intensity values of adenomas and metastases
(mean values, 213 versus 18), and differentiation of both lesions
were 100% accurate if the cutoff value of the signal intensity
selected was 36–106 with no need for reference tissue in
measurement.
Our study stated that chemical shift subtraction MRI can pro-
vides highly confident differentiation of adrenal adenomas from
non-adenomatous lesions just by measuring the signal intensityPlease cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egypof the lesion only in the subtracted chemical shift image without
using of any reference organ and without calculation of any for-
mula with the cutoff of signal intensity 47–108, so any lesion with
signal intensity more than 108 is indicating adenoma while any
lesion less than 47 indicate non adenoma
We faced some limitation during current study while applying
subtraction technique including first, the small number of adrenal
lesions especially the functioning adenomas, non-adenomatous
and metastatic adrenal lesion, second, all included studies were
done using one MR scanner which may revealed other variable
results if done using different scanners or other versions and lastly
that no equivocal lesion was present among our cases such as
lipid-poor adenomas.
In conclusion, the chemical shift MR imaging is being estab-
lished as an important sequence that can give much help in diag-
nosing adrenal tumors, still some debate among various studies
had been found in order to select the best chemical shift technique
for evaluating adrenal lesions. In our study, the signal intensity
index and adrenal-to-spleen ratios with the two used formulae,
were the most reliable evaluation methods with no overlap found
between adrenal adenomas and non-adenomatous solid tumors.
Chemical shift subtraction MRI can also provide highly confident
differentiation just by measuring the signal intensity of the lesion
only in the subtracted chemical shift image without using of any
reference organ.ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
Fig. 6. 32-years female with biopsy proven left adrenal sarcoma. A, Axial in-phase MR image shows left adrenal mass (arrow) that slightly inhomogeneous iso to slight hypo
intense in signal compared to paraspinal muscle. B, Signal cancellation of mass (arrow) on opposed-phase MR image is obscure compared with that seen on A. Signal intensity
index was 3.5%, adrenal to spleen ratio was 0.97, adrenal to spleen ratio% was 3.1%, adrenal to liver ratio% was 1.14% and adrenal to muscle ratio% was 3.11%. C, T2-
wieghted MR image shows heterogeneous hyperintense signal of the left adrenal mass with central breakdown necrotic area.
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Fig. 7. 41-year female with laboratory and biopsy proven non-functional adenoma in left adrenal gland. A, Axial in-phase MR image shows left adrenal mass (arrow) that
slightly iso- to slight hyper intense in signal compared to spleen. B, Axial opposed-phase MR image shows lower signal intensity of mass (arrow) compared to spleen and
compared to its signal on A. Signal intensity index was 71.2%, adrenal to spleen ratio was 0.30, adrenal to spleen ratio% was 69.89%, adrenal to liver ratio% was 63.62% and
adrenal to muscle ratio% was 69.85%. C, Chemical shift subtraction MR image shows marked signal increase throughout mass with signal intensity averaging 488.98,
indicating lipid content.
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Fig. 8. 54-year male with left adrenal metastasis from lung cancer managed with chemotherapy. A, Axial in-phase MR image shows left adrenal mass (arrow) that hyper
intense in signal compared to spleen. B, Signal cancellation of mass (arrow) on opposed-phase MR image is obscure compared with that seen on A. Signal intensity index was
1.1%, adrenal to spleen ratio was 0.80, adrenal to spleen ratio% was 19.71%, adrenal to liver ratio% was 7.11% and adrenal to muscle ratio% was 7.55%. C, Chemical shift
subtraction MR image shows decreased signal throughout mass (arrow) with signal intensity averaging 13.52, indicating lipid content.
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Fig. 9. 29-year female with repeated attacks of paroxysmal hypertension, the excisional biopsy revealed right suprarenal pheochromocytoma. A, Axial in-phase MR image
shows right adrenal mass (yellow arrow) that expressed iso to slight hyperintense signal compared to spleen. B, Axial opposed-phase MR image shows no significant drop of
signal noted in the right adrenal mass lesion (yellow arrow) with its signal intensity index was 5%, adrenal to spleen ratio was 0.97, adrenal to spleen ratio 3.19%, adrenal to
liver ratio% was 6.36% and adrenal to muscle ratio% was9.31%. C, Heavy T2-weighted image shows hyperintense signal of the right adrenal mass lesion (yellow arrow) (light
bulb sign). D, Chemical shift subtraction MR image shows decreased signal of the right adrenal mass (yellow arrow) with signal intensity averaging 4.169, indicating absence
of lipid content within the right adrenal mass lesion.
A.H. Afifi et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxx 13Acknowledgment
The authors thank Mr. Shehata Farag Shehata, MD, lecturer of
biostatistics, Alexandria University, for assistance with the statisti-
cal analysis done in this study.References
[1] Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT:
prevalence of adrenal disease in 1049 consecutive adrenal masses in patients
with no known malignancy. AJR Am J Roentgenol 2008;190:1163–8.
[2] Boland GW. Adrenal imaging: why, when, what, and how? Part 1. Why and
when to image? AJR Am J Roentgenol 2010;195:W377–81.
[3] Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions:
principles, techniques, and algorithms for imaging characterization. Radiology
2008;249:756–75.
[4] Cawood TJ, Hunt PJ, O’Shea D, Cole D, Soule S. Recommended evaluation of
adrenal incidentalomas is costly, has high false-positive rates and confers a
risk of fatal cancer that is similar to the risk of the adrenal lesion becoming
malignant; time for a rethink? Eur J Endocrinol 2009;161:513–27.
[5] Lattin Jr GE, Sturgill ED, Tujo CA, Marko J, Sanchez-Maldonado KW, Craig WD,
et al. From the radiologic pathology archives: adrenal tumors and tumor-like
conditions in the adult: radiologic-pathologic correlation. Radiographics
2014;34:805–29.
[6] Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, et al.
Prevalence of adrenal incidentaloma in a contemporary computerized
tomography series. J Endocrinol Invest 2006;29:298–302.
[7] Libe R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial
to sporadic diseases. Eur J Endocrinol 2005;153:477–87.Please cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egyp[8] Leung K, Stamm M, Raja A, Low G. Pheochromocytoma: the range of
appearances on ultrasound, CT, MRI, and functional imaging. AJR Am J
Roentgenol 2013;200:370–8.
[9] Korobkin M, Giordano TJ, Brodeur FJ, Francis IR, Siegelman ES, Quint LE, et al.
Adrenal adenomas: relationship between histologic lipid and CT and MR
findings. Radiology 1996;200:743–7.
[10] Elsayes KM, Mukundan G, Narra VR, Lewis Jr JS, Shirkhoda A, Farooki A, et al.
Adrenal masses: mr imaging features with pathologic correlation.
Radiographics 2004;24(Suppl 1):S73–86.
[11] Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of
unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal
adenomas. AJR Am J Roentgenol 2004;183:215–9.
[12] Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S.
Characterization of adrenal masses (<5 cm) by use of chemical shift MR
imaging: observer performance versus quantitative measures. AJR Am J
Roentgenol 1995;165:91–5.
[13] Bilbey JH, McLoughlin RF, Kurkjian PS, Wilkins GE, Chan NH, Schmidt N, et al.
MR imaging of adrenal masses: value of chemical-shift imaging for
distinguishing adenomas from other tumors. AJR Am. J. Roentgenol.
1995;164:637–42.
[14] Uhl M, Altehoefer C, Kontny U, Il’yasov K, Buchert M, Langer M. MRI-diffusion
imaging of neuroblastomas: first results and correlation to histology. Eur
Radiol 2002;12:2335–8.
[15] Al-Hawary MM, Francis IR, Korobkin M. Non-invasive evaluation of the
incidentally detected indeterminate adrenal mass. Best Pract Res Clin
Endocrinol Metab 2005;19:277–92.
[16] Sandrasegaran K, Patel AA, Ramaswamy R, Samuel VP, Northcutt BG, Frank MS,
et al. Characterization of adrenal masses with diffusion-weighted imaging. AJR
Am J Roentgenol 2011;197:132–8.
[17] Tsushima Y, Takahashi-Taketomi A, Endo K. Diagnostic utility of diffusion-
weighted MR imaging and apparent diffusion coefficient value for the
diagnosis of adrenal tumors. J Magn Reson Imag 2009;29:112–7.ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
14 A.H. Afifi et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxx[18] Park BK, Kim CK, Kim B, Lee JH. Comparison of delayed enhanced CT and
chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
Radiology 2007;243:760–5.
[19] Seo JM, Park BK, Park SY, Kim CK. Characterization of lipid-poor adrenal
adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol
2014;202:1043–50.
[20] Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S. Characterization of adrenal
tumors by chemical shift fast low-angle shot MR imaging: comparison of four
methods of quantitative evaluation. AJR Am J Roentgenol 2003;180:1649–57.
[21] Adam SZ, Nikolaidis P, Horowitz JM, Gabriel H, Hammond NA, Patel T, et al.
Chemical shift MR imaging of the adrenal gland: principles, pitfalls, and
applications. Radiographics 2016;36:414–32.
[22] McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR.
An imaging algorithm for the differential diagnosis of adrenal adenomas and
metastases. AJR Am J Roentgenol 1995;165:1453–9.Please cite this article in press as: Afifi AH et al. Role of quantitative chemical sh
discriminating adenomatous from non adenomatous adrenal solid lesions. Egyp[23] Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign
adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology
1992;185:345–51.
[24] Reinig JW, Stutley JE, Leonhardt CM, Spicer KM, Margolis M, Caldwell CB.
Differentiation of adrenal masses with MR imaging: comparison of techniques.
Radiology 1994;192:41–6.
[25] Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with
chemical shift, fast low-angle shot MR imaging. Radiology 1993;186:705–9.
[26] Barzilay JI, Pazianos AG. Adrenocortical carcinoma. Urol Clin North Am
1989;16:457–68.
[27] Savci G, Yazici Z, Sahin N, Akgoz S, Tuncel E. Value of chemical shift subtraction
MRI in characterization of adrenal masses. AJR Am J Roentgenol
2006;186:130–5.
[28] Korivi BR, Elsayes KM. Cross-sectional imaging work-up of adrenal masses.
World J Radiol 2013;5:88–97.ift magnetic resonance imaging and chemical shift subtraction technique in
t J Radiol Nucl Med (2016), http://dx.doi.org/10.1016/j.ejrnm.2016.11.007
